摩根大通将举办第五届全球医疗健康产业上海年会

Core Insights - Morgan Stanley will host the fifth Global Healthcare Industry Shanghai Conference from October 16 to 17, focusing on investment trends, industry innovation, and financing in the Chinese healthcare sector [1] - The Chinese healthcare industry has seen significant growth, driven by strong licensing deals for innovative drugs, solid fundamentals of biotech and pharmaceutical companies, and favorable domestic policies [1] - Shanghai is recognized as a hub for the healthcare industry in China, with a strong research and development capability, and local innovative pharmaceutical companies leading in financing transactions [1] Investment Trends - Investor interest in Chinese healthcare companies is rising due to the large population base, rapidly expanding market size, and improving innovation capabilities of Chinese firms [2] - Morgan Stanley emphasizes its commitment to enhancing healthcare investment banking services to support both domestic and international clients [2] Event Highlights - The conference will feature over 170 one-on-one or small group investor dialogues, providing a platform for business leaders and investors to exchange views and identify new opportunities in the global healthcare landscape [1] - Morgan Stanley also hosts the largest annual healthcare investment conference in San Francisco, attracting over 600 listed and private companies and more than 8,000 participants [2]